Resveratrol inhibits mucus overproduction and MUC5AC expression in a murine model of asthma

Molecular Medicine Reports

Volumn 13, Issue 1, 2016, Pages 287-294

  Ni, Zhen Hua ^a   Tang, Ji Hong ^a   Chen, Guo ^a   Lai, Yi Min ^a   Chen, Qing Ge ^a   Li, Zao ^a   Yang, Wei ^a   Luo, Xu Min ^a   Wang, Xiong Biao ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Asthma; Human CLCA1; Mucin 5AC; Mucosal; Murine CLCA3; Resveratrol

Indexed keywords

CALCIUM ACTIVATED CHLORIDE CHANNEL; CALCIUM ACTIVATED CHLORIDE CHANNEL 3; MUCIN 5AC; RESVERATROL; SODIUM CHLORIDE; UNCLASSIFIED DRUG; STILBENE DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG PARENCHYMA; MALE; MOUSE; MUCUS SECRETION; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; METABOLISM; MUCUS; PATHOLOGY; PNEUMONIA;

ANIMALS; ASTHMA; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUNG; MICE, INBRED BALB C; MUCIN 5AC; MUCUS; PNEUMONIA; STILBENES;

EID: 84954231472     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4520     Document Type: Article

References (25)

1. Anandan C, Nurmatov U, van Schayck OCP and Sheikh A: Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 65: 152-167, 2010.
2. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA and Boulet LP: Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health 12: 204, 2012.
3. Evans CM, Kim K, Tuvim MJ and Dickey BF: Mucus hypersecretion in asthma: Causes and effects. Curr Opin Pulm Med 15: 4-11, 2009.
4. Voynow JA, Young LR, Wang Y, Horger T, Rose MC and Fischer BM: Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 276: L835-L843, 1999.
5. Izuhara K, Ohta S, Shiraishi H, Suzuki S, Taniguchi K, Toda S, Tanabe T, Yasuo M, Kubo K, Hoshino T and Aizawa H: The mechanism of mucus production in bronchial asthma. Curr Med Chem 16: 2867-2875, 2009.
6. Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, Fujisawa Y, Nishimura O and Fujino M: Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 98: 5175-5180, 2001.
7. Kang JH, Lee EH, Park SW and Chung IY: MUC5AC expression through bidirectional communication of Notch and epidermal growth factor receptor pathways. J Immunol 187: 222-229, 2011.
8. Lee M, Kim S, Kwon OK, Oh SR, Lee HK and Ahn K: Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int Immunopharmacol 9: 418-424, 2009.
9. Royce SG, Dang W, Yuan G, Tran J, El Osta A, Karagiannis TC and Tang ML: Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease. Pathobiol Aging Age Relat Dis 1, 2011.
10. Chiba T, Uchi H, Tsuji G, Gondo H, Moroi Y and Furue M: Arylhydrocarbon receptor (AhR) activation in airway epithelial cells induces MUC5AC via reactive oxygen species (ROS) production. Pulm Pharmacol Ther 24: 133-140, 2011.
11. Lee SY, Lee HJ, Sikder MA, Shin HD, Kim JH, Chang GT, Seok JH and Lee CJ: Resveratrol inhibits mucin gene expression, production and secretion from airway epithelial cells. Phytother Res 26: 1082-1087, 2012.
12. Ni Z, Tang J, Cai Z, Yang W, Zhang L, Chen Q, Zhang L and Wang X: A new pathway of glucocorticoid action for asthma treatment through the regulation of PTEN expression. Respir Res 12: 47, 2011.
13. Underwood S, Foster M, Raeburn D, Bottoms S and Karlsson JA: Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J 8: 2104-2113, 1995.
14. Pfaffl MW, Horgan GW and Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36, 2002.
15. Ni Z, Tao K, Chen G, Chen Q, Tang J, Luo X, Yin P, Tang J and Wang X: CLPTM1L is overexpressed in lung cancer and associated with apoptosis. PLoS One 7: e52598, 2012.
16. Wang G, Xu Z, Wang R, Al-Hijji M, Salit J, Strulovici-Barel Y, Tilley AE, Mezey JG and Crystal RG: Genes associated with MUC5AC expression in small airway epithelium of human smokers and non-smokers. BMC Med Genomics 5: 21, 2012.
17. Patel AC, Brett TJ and Holtzman MJ: The role of CLCA proteins in inflammatory airway disease. Annu Rev Physiol 71: 425-449, 2009.
18. Song L, Liu D, Wu C, Wu S, Yang J, Ren F and Li Y: Antibody to mCLCA3 suppresses symptoms in a mouse model of asthma. PLoS One 8: e82367, 2013.
19. Mei L, He L, Wu SS, Zhang B, Xu YJ, Zhang ZX, Zhao JP and Zhang HL: Murine calcium-activated chloride channel family member 3 induces asthmatic airway inflammation independently of allergen exposure. Chin Med J (Engl) 126: 3283-3288, 2013.
20. Winpenny JP, Marsey LL and Sexton DW: The CLCA gene family: Putative therapeutic target for respiratory diseases. Inflamm Allergy Drug Targets 8: 146-160, 2009.
21. Nakano T, Inoue H, Fukuyama S, Matsumoto K, Matsumura M, Tsuda M, Matsumoto T, Aizawa H and Nakanishi Y: Niflumic acid suppresses interleukin-13-induced asthma phenotypes. Am J Respir Crit Care Med 173: 1216-1221, 2006.
22. Matsunaga Y, Inoue H, Fukuyama S, Yoshida H, Moriwaki A, Matsumoto T, Matsumoto K, Asai Y, Kubo M, Yoshimura A and Nakanishi Y: Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma. Biochem Biophys Res Commun 404: 261-267, 2011.
23. Aich J, Mabalirajan U, Ahmad T, Khanna K, Rehman R, Agrawal A and Ghosh B: Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A). Int Immunopharmacol 14: 438-443, 2012.
24. Yang CJ, Lin CY, Hsieh TC, Olson SC and Wu JM: Control of eotaxin-1 expression and release by resveratrol and its metabolites in culture human pulmonary artery endothelial cells. Am J Cardiovasc Dis 1: 16-30, 2011.
25. Tan Y and Lim LH: trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation. Br J Pharmacol 155: 995-1004, 2008.